Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/19/17 → 7/19/20 |
Funding
- PRA Health Sciences (GS-US-418-3898 // GS-US-418-3898)
- Gilead Sciences, Inc (GS-US-418-3898 // GS-US-418-3898)
Prot# GS-US-418-3898: Combined Phase 2b/3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to Severely Active Ulcerative Coliti
- Hanauer, stephen B (PD/PI)
Project: Research project